Evaluation of the MRX PT DOAC assay for detection of clinically relevant factor Xa inhibitor drug levels.
Salter B, Moffat K, Carlino S, Dobson-Storr J, Beckett L, Broomhead E, Onelöv L, Ge S, Atalla M, Melika R, Bansal S, Kitchen S, Crowther M, Mithoowani S.
Salter B, et al. Among authors: ge s.
J Thromb Haemost. 2024 Dec 13:S1538-7836(24)00725-6. doi: 10.1016/j.jtha.2024.12.005. Online ahead of print.
J Thromb Haemost. 2024.
PMID: 39675568